The occurrence of medication side effects in women who received endocrine treatment for breast cancer may indicate a decreased risk of cancer recurrence and act as a marker for treatment success.
The occurrence of medication side effects, such as vasomotor symptoms and arthritis, in women who received endocrine treatment for breast cancer may indicate a decreased risk of cancer recurrence and act as a marker for treatment success, according to a study published online Oct. 30 in The Lancet Oncology.
Jack Cuzick, PhD, of the University of London and colleagues examined the association between self-reported vasomotor or joint symptoms and breast cancer recurrence among 3,964 participants in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) trial.
Among the 37.5% of women reporting new vasomotor symptoms at the 3-month follow-up visit, recurrence of breast cancer was significantly lower than for those not reporting symptoms (223 during 10,752 women-years of follow-up vs. 366 during 11,573 women-years of follow-up). Similarly, among women reporting new joint symptoms, breast cancer recurrence was less frequent than for those not reporting symptoms (158 during 9,242 women-years of follow-up vs. 366 during 11,573 women-years of follow-up).
Cuzick J, Sestak I, Cella D, et al. Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial. Lancet Oncol. doi:10.1016/S1470-2045(08)70259-6.
Inactivated COVID-19 vaccines in pregnancy: No impact on neonatal outcome, study finds
November 28th 2023A comprehensive cohort study explored the impact of inactivated COVID-19 vaccines administered within 3 months before conception, revealing reassuring findings that neonatal outcomes, including preterm birth and NICU admission, remain unaffected.
Read More
A closer look at women's concerns on breast density in clinician discussions
November 27th 2023A study found variations in discussions about breast density based on race and ethnicity, leading researchers to urge enhanced cultural competency and shared decision-making to bridge critical gaps in breast density conversations.
Read More
High rates of perinatal anxiety in women from low- and middle-income countries
November 24th 2023A recent comprehensive study reveals that 1 in 5 women in low- and middle-income countries grapple with perinatal anxiety disorders, shedding light on a critical yet often overlooked mental health challenge affecting maternal and infant outcomes in these regions.
Read More